Results for untargeted MS search on m/z: (+/-) mode
Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
---|---|---|---|---|---|---|---|---|---|---|
AN001832 | 121.05 | 11.81 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 184.07 | 5.09 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 184.07 | 5.87 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 186.06 | 11.05 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 300.29 | 1.47 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 332.33 | 1.71 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 339.29 | 4.88 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 339.29 | 5.08 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 360.36 | 2.48 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 365.3 | 5.08 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 367.32 | 5.43 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 369.13 | 1.63 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 369.35 | 5.14 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 369.35 | 10.75 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 369.35 | 11.27 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 369.35 | 11.71 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 369.35 | 12.12 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 369.35 | 12.22 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 369.35 | 12.43 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 370.36 | 5.12 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 371.27 | 5.07 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 371.77 | 5.06 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 386.76 | 5.8 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 398.33 | 1.35 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 398.76 | 5.36 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 399.77 | 5.86 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 400.28 | 5.86 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 400.34 | 1.83 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 411.09 | 0.75 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 412.78 | 5.95 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 413.79 | 6.56 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 426.36 | 2 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 428.37 | 2.7 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 449.05 | 0.75 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 470.21 | 2.71 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 481.46 | 10.92 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 496.34 | 1.63 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 509.49 | 10.94 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 509.49 | 11.33 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 509.49 | 11.71 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 520.51 | 5.92 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 522.36 | 1.64 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 522.36 | 1.79 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 523.47 | 10.76 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 523.47 | 11.32 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 524.37 | 2.48 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 529.36 | 2.34 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 532.47 | 5.19 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 533.28 | 3.16 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 535.51 | 11 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 535.51 | 11.35 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 535.51 | 11.74 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 537.4 | 6.43 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 537.52 | 11.72 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 537.52 | 11.95 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 538.52 | 5.92 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 539.52 | 5.91 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 549.49 | 10.78 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 550.39 | 2.64 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 551.5 | 5.16 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 551.5 | 11.18 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 551.5 | 11.71 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 551.51 | 11.96 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 551.53 | 11.81 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 558.49 | 5.32 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 560.5 | 5.94 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 561.52 | 6.37 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 561.52 | 10.99 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 561.52 | 11.36 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 563.47 | 6.47 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 563.54 | 11.36 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 563.54 | 11.71 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 563.54 | 11.94 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 563.54 | 12.07 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 565.56 | 11.95 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 565.56 | 12.07 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 566.55 | 6.65 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 575.5 | 10.28 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 575.5 | 10.82 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 576.51 | 10.82 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 576.57 | 7.35 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 577.52 | 5.08 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 577.52 | 6.02 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 577.52 | 7.82 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 577.52 | 10.63 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 577.52 | 10.78 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 577.52 | 11.18 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 577.52 | 11.57 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 577.52 | 11.72 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 579.53 | 11.56 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 579.54 | 11.95 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 589.48 | 6.54 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 589.51 | 6.66 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 589.56 | 11.36 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 589.56 | 11.71 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 591.57 | 11.95 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 593.59 | 12.08 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 594.58 | 7.35 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 599.5 | 4.51 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 601.52 | 4.93 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 601.52 | 10.85 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 603.53 | 5.16 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 603.53 | 5.38 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 603.53 | 10.29 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 603.53 | 10.64 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 603.53 | 11.2 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 603.53 | 11.59 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 605.55 | 5.68 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 605.55 | 5.85 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 605.55 | 11.55 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 605.55 | 11.94 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 607.56 | 11.87 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 612.56 | 7.24 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 614.55 | 6.74 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 615.5 | 6.7 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 617.59 | 11.94 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 619.6 | 12.07 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 621.63 | 12.16 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 622.61 | 8.02 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 625.52 | 4.56 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 627.54 | 5.1 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 629.55 | 5.37 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 629.55 | 5.55 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 629.55 | 11.25 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 630.55 | 5.15 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 631.47 | 6.7 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 631.57 | 5.78 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 631.57 | 11.55 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 631.57 | 11.87 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 633.49 | 7.24 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 633.58 | 6.28 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 633.58 | 11.86 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 633.58 | 12.03 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 633.6 | 12.12 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 638.58 | 7.3 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 639.5 | 6.53 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 642.58 | 7.44 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 643.57 | 5.71 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 645.54 | 7.89 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 645.6 | 8.01 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 645.62 | 12.07 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 647.65 | 12.16 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 648.63 | 8 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 649.65 | 12.23 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 650.64 | 8.67 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 653.55 | 5.13 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 655.57 | 5.54 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 657.58 | 6.01 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 658.61 | 8.36 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 659.5 | 7.31 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 659.6 | 6.41 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 659.6 | 11.86 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 659.63 | 12.43 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 660.57 | 8.03 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 661.52 | 7.9 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 661.61 | 12.01 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 664.52 | 4.88 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 665.5 | 6.58 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 667.53 | 7.25 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 668.6 | 7.43 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 668.63 | 11.26 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 671.57 | 7.92 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 671.61 | 7.99 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 672.59 | 7.97 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 673.63 | 8.67 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 673.66 | 12.15 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 674.51 | 5.69 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 674.63 | 8.66 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 675.54 | 4.41 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 675.66 | 12.22 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 676.53 | 6.31 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 678.51 | 4.5 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 683.5 | 7.25 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 685.56 | 5.08 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 686.58 | 8 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 687.54 | 7.95 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 688.53 | 5.1 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 688.6 | 8.68 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 689.56 | 4.72 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 689.56 | 11.29 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 690.53 | 5.44 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 692.52 | 4.81 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 692.53 | 5.94 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 692.56 | 5.55 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 693.56 | 5.55 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 698.56 | 5.1 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 700.53 | 5.83 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 700.57 | 5.27 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 701.56 | 4.51 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 702.54 | 6.37 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 703.57 | 5.08 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 704.52 | 4.64 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 704.56 | 7.01 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 705.59 | 5.29 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 705.81 | 5.07 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 706.54 | 4.92 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 706.54 | 5.13 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 708.77 | 5.14 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 714.54 | 5.11 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 716.53 | 5.49 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 716.56 | 5.11 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 716.56 | 5.61 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 717.57 | 5.48 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 718.54 | 4.94 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 718.54 | 5.1 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 718.54 | 6.03 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 718.57 | 6.14 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 718.58 | 5.74 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 719.57 | 10.3 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 719.58 | 5.66 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 719.58 | 5.83 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 720.55 | 5.33 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 720.58 | 6.04 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 720.59 | 6.26 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 721.57 | 6.2 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 721.58 | 6.26 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 722.59 | 6.29 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 724.53 | 5.7 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 726.54 | 6 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 726.54 | 6.2 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 728.56 | 6.42 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 730.54 | 4.72 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 730.54 | 5.01 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 730.54 | 5.09 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 730.54 | 5.76 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 730.57 | 7.07 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 731.61 | 5.75 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 731.65 | 10.46 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 732.55 | 5.23 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 732.55 | 5.3 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 732.56 | 6.37 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 732.57 | 5.84 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 732.58 | 5.96 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 732.59 | 5.74 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 732.78 | 5.27 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 733.58 | 5.74 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 734.57 | 5.58 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 734.57 | 5.8 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 734.79 | 5.24 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 734.8 | 5.8 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 735.55 | 10.29 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 735.57 | 5.82 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 736.57 | 5.29 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 736.57 | 6.18 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 738.54 | 5.59 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 738.66 | 9.32 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 740.53 | 5.38 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 740.54 | 5.12 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 740.68 | 9.8 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 741.53 | 5.07 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 742.03 | 5.18 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 742.54 | 5.5 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 742.57 | 6.35 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 743.57 | 5.66 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 744.53 | 5.12 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 744.55 | 5.03 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 744.56 | 6.08 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 744.58 | 5.98 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 744.58 | 6.21 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 744.59 | 5.77 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 745.58 | 6.2 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 745.59 | 5.77 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 746.57 | 5.54 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 746.57 | 6.05 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 746.61 | 6.32 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 747.57 | 5.68 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 747.57 | 5.79 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 748.54 | 5.51 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 748.58 | 6.02 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 748.59 | 6.15 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 748.59 | 6.71 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 748.62 | 6.98 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 749.61 | 6.72 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 750.54 | 5.73 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 750.55 | 5.94 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 750.56 | 4.92 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 750.71 | 11.97 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 751.57 | 5.15 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 752.52 | 5.05 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 752.56 | 6.2 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 752.56 | 6.39 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 752.73 | 12.12 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 754.54 | 4.62 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 754.57 | 6.34 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 754.57 | 6.89 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 754.58 | 5.76 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 754.73 | 10.91 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 755.03 | 5.3 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 756.55 | 4.82 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 756.55 | 5.09 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 756.59 | 7.14 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 757.56 | 5.77 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 757.67 | 10.48 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 758.57 | 5.16 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 758.57 | 5.36 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 758.57 | 5.97 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 758.6 | 7.71 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 759.59 | 9.32 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 759.64 | 6.47 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 760.58 | 5.67 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 760.59 | 5.87 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 760.81 | 5.36 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 760.82 | 5.87 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 761.6 | 9.8 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 762.59 | 5.12 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 762.6 | 6.26 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 762.6 | 6.51 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 762.94 | 5.87 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 763.1 | 5.86 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 763.53 | 5.29 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 763.6 | 6.5 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 764.52 | 5.17 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 764.56 | 5.69 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 764.59 | 5.87 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 764.68 | 9.39 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 765.73 | 11.33 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 766.54 | 5.07 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 766.55 | 5.45 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 766.57 | 6.19 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 766.69 | 9.84 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 767.56 | 6.11 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 767.57 | 5.51 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 768.04 | 5.32 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 768.55 | 4.93 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 768.56 | 6.03 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 768.56 | 6.7 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 768.57 | 5.85 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 768.57 | 6.16 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 768.59 | 5.66 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 768.71 | 10.3 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 769.56 | 5.52 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 769.56 | 6.67 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 769.57 | 5.78 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 770.06 | 5.83 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 770.57 | 6.08 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 770.58 | 6.56 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 770.6 | 5.81 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 770.6 | 6.31 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 771.06 | 5.87 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 771.52 | 5.19 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 771.52 | 5.49 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 771.59 | 5.86 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 772.07 | 5.86 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 772.56 | 5.8 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 772.58 | 5.64 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 772.59 | 6.73 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 772.62 | 6.38 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 772.62 | 6.9 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 773.55 | 5.79 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 773.57 | 5.72 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 773.57 | 5.9 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 774.55 | 5.54 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 774.58 | 5.61 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 774.6 | 6.21 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 774.64 | 7.04 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 775.55 | 5.55 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 775.55 | 5.79 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 775.57 | 5.6 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 775.6 | 6.21 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 776.56 | 5.78 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 776.56 | 5.97 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 776.57 | 6.19 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 776.58 | 5.12 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 776.65 | 7.69 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 777.57 | 6.18 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 778.54 | 4.47 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 778.57 | 6.22 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 778.57 | 6.4 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 778.59 | 5.56 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 778.61 | 6.68 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 779.54 | 5.23 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 779.56 | 5.87 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 780.04 | 5.25 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 780.06 | 5.87 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 780.55 | 4.71 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 780.55 | 4.83 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 780.59 | 6.88 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 780.75 | 10.93 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 782.57 | 4.94 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 782.57 | 5.24 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 782.6 | 7.38 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 783.07 | 5.85 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 783.56 | 6.18 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 783.57 | 4.97 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 784.58 | 5.85 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 784.58 | 6.32 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 784.59 | 5.42 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 784.59 | 5.53 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 784.59 | 5.72 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 784.66 | 7.35 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 784.81 | 5.88 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 785.08 | 5.91 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 785.57 | 5.23 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 785.6 | 9.39 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 785.61 | 6.52 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 785.65 | 6.55 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 786.6 | 5.94 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 786.84 | 5.94 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 787.62 | 9.84 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 787.67 | 7.18 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 787.72 | 11.3 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 788.54 | 5.43 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 788.56 | 5.52 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 788.62 | 6.35 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 788.62 | 6.57 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 788.65 | 7.1 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 788.66 | 7.35 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 788.67 | 7.17 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 788.84 | 5.93 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 789.64 | 10.27 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 789.66 | 7.18 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 790.55 | 5.07 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 790.55 | 5.27 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 790.55 | 6.05 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 790.56 | 5.41 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 790.56 | 5.93 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 790.56 | 6.19 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 790.57 | 5.33 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 790.57 | 5.68 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 790.64 | 7.2 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 790.86 | 6.58 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 791.55 | 5.26 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 791.56 | 6.03 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 792.55 | 5.11 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 792.56 | 5.25 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 792.56 | 5.94 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 792.57 | 5.47 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 792.57 | 5.8 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 792.59 | 5.56 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 792.71 | 9.89 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 793.05 | 5.29 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 793.06 | 5.92 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 793.55 | 5.06 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 793.56 | 5.89 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 794.06 | 5.41 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 794.56 | 5.17 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 794.58 | 5.89 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 794.58 | 6.08 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 794.72 | 10.32 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 795.57 | 5.01 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 795.58 | 5.92 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 796.07 | 5.93 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 796.51 | 5.14 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 796.53 | 5.36 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 796.58 | 5.58 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 796.6 | 6.55 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 796.6 | 6.73 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 796.61 | 6.18 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 796.62 | 6.36 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 796.74 | 10.75 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 797.51 | 5.13 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 797.53 | 5.35 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 797.6 | 6.54 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 797.61 | 6.18 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 798.55 | 5.85 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 798.57 | 5.77 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 798.6 | 5.74 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 798.64 | 6.68 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 799.56 | 5.84 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 799.67 | 6.81 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 800.56 | 5.83 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 800.62 | 6.26 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 800.62 | 7.39 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 800.65 | 7.12 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 801.55 | 5.84 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 801.68 | 7.54 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 801.69 | 10.72 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 802.62 | 6.24 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 802.63 | 6.9 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 802.64 | 8.02 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 803.64 | 6.9 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 803.69 | 11.33 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 804.56 | 4.53 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 804.68 | 8.35 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 805.56 | 5.2 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 805.56 | 5.31 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 806.06 | 5.33 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 806.55 | 6.05 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 806.57 | 4.84 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 806.57 | 5.09 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 806.76 | 10.98 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 806.76 | 11.24 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 807.57 | 5.9 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 808.07 | 5.91 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 808.58 | 5.49 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 808.59 | 5.29 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 808.74 | 10.54 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 808.77 | 11.63 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 810.6 | 5.74 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 810.6 | 5.93 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 810.67 | 7.32 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 810.76 | 10.9 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 811.6 | 5.91 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 811.66 | 6.56 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 811.74 | 11.26 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 812.53 | 5.29 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 812.62 | 6.05 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 812.62 | 6.21 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 812.62 | 6.55 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 812.7 | 8.02 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 813.64 | 9.89 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 813.68 | 7.15 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 813.73 | 11.34 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 814.05 | 5.85 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 814.51 | 5.28 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 814.54 | 5.83 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 814.54 | 5.87 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 814.63 | 6.59 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 815.54 | 5.84 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 815.65 | 10.36 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 815.7 | 7.87 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 815.75 | 11.72 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 816.52 | 5.26 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 816.57 | 6.08 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 816.59 | 5.71 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 816.66 | 7.15 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 817.65 | 7.23 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 817.65 | 7.35 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 817.67 | 10.72 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 817.76 | 11.36 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 818.57 | 6.55 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 818.58 | 5.91 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 818.6 | 5.52 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 818.72 | 9.96 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 820.53 | 5.25 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 820.58 | 5.39 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 820.61 | 5.75 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 820.62 | 6.15 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 820.74 | 10.35 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 822.53 | 5.23 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 822.6 | 5.61 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 822.61 | 6.73 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 822.75 | 10.76 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 822.79 | 11.5 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 823.53 | 5.27 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 823.61 | 6.58 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 824.1 | 6.57 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 824.54 | 5.57 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 824.54 | 5.79 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 824.56 | 5.94 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 824.65 | 7.06 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 824.8 | 11.82 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 826.56 | 5.93 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 826.58 | 6.56 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 828.55 | 5.13 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 828.56 | 5.88 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 828.65 | 6.93 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 829.71 | 11.35 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 829.73 | 11.16 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 830.57 | 4.67 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 830.75 | 10.87 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 831.72 | 11.72 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 832.58 | 4.86 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 832.58 | 5.13 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 832.58 | 5.58 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 832.77 | 11.27 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 832.78 | 11.02 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 834.6 | 5.33 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 834.6 | 5.53 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 834.6 | 5.73 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 834.6 | 6.06 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 834.75 | 10.58 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 834.79 | 11.62 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 835.6 | 5.72 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 835.75 | 10.32 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 836.54 | 5.16 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 836.55 | 5.54 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 836.61 | 5.76 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 836.62 | 5.94 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 836.67 | 7.13 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 836.81 | 11.72 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 837.55 | 5.11 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 837.62 | 6.58 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 837.74 | 11.06 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 837.74 | 11.25 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 837.77 | 10.96 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 838.55 | 5.34 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 838.62 | 6.57 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 838.63 | 6.26 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 838.68 | 7.87 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 838.75 | 11.04 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 838.76 | 10.97 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 838.78 | 11.32 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 838.82 | 11.96 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 839.65 | 9.95 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 839.75 | 11.39 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 840.54 | 5.34 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 840.54 | 5.88 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 840.56 | 5.8 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 840.65 | 6.81 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 840.71 | 10.57 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 841.54 | 5.89 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 841.67 | 10.35 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 841.73 | 10.96 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 842.53 | 5.35 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 842.53 | 5.85 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 842.55 | 5.8 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 842.66 | 7.27 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 843.16 | 0.75 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 843.53 | 5.85 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 843.68 | 10.74 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 844.53 | 5.08 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 844.54 | 5.85 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 844.68 | 7.9 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 845.55 | 5.9 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 845.7 | 11.14 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 845.8 | 11.71 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 846.54 | 5.3 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 846.74 | 10.72 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 846.75 | 10.41 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 847.76 | 10.4 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 848.05 | 5.85 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 848.54 | 5.36 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 848.56 | 5.92 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 848.77 | 10.79 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 848.8 | 11.54 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 849.01 | 10.79 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 849.54 | 5.34 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 850.54 | 5.34 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 850.55 | 5.85 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 850.79 | 11.18 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 850.82 | 11.83 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 851.03 | 11.17 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 851.14 | 10.8 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 852.58 | 6.56 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 852.83 | 12 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 853.15 | 11.16 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 854.57 | 4.55 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 854.73 | 10.78 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 855.52 | 5.05 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 855.57 | 5.12 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 856.58 | 4.75 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 856.74 | 10.76 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 856.74 | 11.15 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 856.74 | 11.3 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 857.74 | 11.39 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 857.74 | 11.72 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 857.76 | 11.56 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 858.59 | 5.15 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 858.79 | 11.27 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 859.72 | 10.66 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 859.74 | 11.69 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 859.75 | 11.94 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 860.61 | 5.75 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 860.61 | 6.4 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 860.77 | 10.63 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 860.81 | 11.39 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 860.81 | 11.62 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 861.53 | 5.05 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 861.76 | 10.35 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 862.51 | 5.24 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 862.62 | 5.07 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 862.86 | 12.14 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 863.78 | 10.75 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 864.64 | 6.34 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 864.64 | 6.7 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 864.8 | 11.34 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 865.79 | 11.37 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 866.54 | 5.93 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 866.66 | 6.91 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 866.78 | 11.39 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 866.82 | 11.71 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 866.85 | 12.08 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 867.54 | 5.89 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 867.67 | 6.9 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 867.68 | 10.41 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 867.74 | 10.96 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 867.79 | 11.73 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 868.56 | 6.57 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 868.68 | 7.35 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 869.7 | 10.79 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 869.79 | 11.94 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 870.69 | 7.91 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 870.7 | 10.79 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 870.73 | 10.39 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 870.75 | 10.25 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 871.72 | 11.15 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 871.75 | 11.32 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 872.54 | 5.3 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 872.77 | 10.47 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 872.77 | 10.59 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 873.7 | 10.03 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 873.73 | 11.56 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 874.55 | 5.42 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 874.55 | 5.53 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 874.79 | 10.83 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 875.03 | 10.83 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 875.84 | 12.07 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 876.57 | 5.97 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 876.83 | 11.85 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 877.05 | 11.19 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 877.16 | 10.83 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 878.59 | 6.56 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 878.74 | 10.7 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 878.82 | 11.56 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 878.85 | 12 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 879.07 | 11.55 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 879.18 | 11.17 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 879.59 | 6.55 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 880.58 | 5.16 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 880.72 | 9.75 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 881.73 | 10.6 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 881.75 | 10.84 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 881.76 | 11.2 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 881.84 | 11.86 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 882.76 | 11.19 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 883.1 | 0.75 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 883.72 | 10.98 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 884.78 | 11.55 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 884.79 | 11.24 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 885.54 | 5.39 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 885.55 | 4.57 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 885.55 | 5.16 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 885.68 | 9.29 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 885.73 | 10.68 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 885.78 | 11.52 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 885.78 | 11.89 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 886.63 | 5.69 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 886.78 | 10.68 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 886.82 | 11.5 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 887.75 | 11.07 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 887.79 | 10.68 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 888.83 | 11.62 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 888.84 | 11.75 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 889.58 | 5.37 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 889.67 | 10.03 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 889.8 | 10.8 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 890.52 | 5.28 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 890.86 | 11.95 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 891.59 | 5.78 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 891.68 | 10.22 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 891.84 | 11.75 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 892.53 | 5.79 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 892.83 | 11.75 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 893.72 | 10.16 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 893.76 | 11.02 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 893.8 | 11.78 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 894.57 | 6.59 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 894.71 | 10.56 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 894.75 | 10.08 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 894.76 | 11.01 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 894.84 | 11.58 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 894.85 | 11.94 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 894.9 | 12.16 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 895.72 | 10.85 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 895.77 | 11.37 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 896.54 | 5.08 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 896.72 | 10.85 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 896.85 | 12.06 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 897.73 | 11.16 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 898.55 | 5.29 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 898.73 | 11.15 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 898.79 | 10.69 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 899.75 | 11.54 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 899.79 | 10.67 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 899.84 | 11.96 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 900.57 | 5.73 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 900.57 | 5.93 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 900.75 | 11.53 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 901.65 | 9.29 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 901.65 | 9.74 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 901.72 | 10.29 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 901.73 | 10.49 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 901.76 | 11.87 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 901.8 | 10.85 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 902.58 | 6.07 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 902.82 | 11.21 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 902.84 | 11.88 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 903.07 | 11.21 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 903.89 | 12.16 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 904.6 | 6.59 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 904.86 | 12.01 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 905.08 | 11.2 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 905.09 | 11.55 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 905.2 | 11.19 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 905.76 | 10.88 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 905.86 | 11.95 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 906.61 | 5.55 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 906.85 | 11.87 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 906.87 | 12.11 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 907.22 | 11.54 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 907.73 | 9.75 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 908.73 | 9.72 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 908.86 | 12.02 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 909.55 | 5.11 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 909.7 | 10.14 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 909.79 | 11.55 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 910.79 | 11.54 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 910.81 | 11.26 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 911.86 | 12.02 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 912.53 | 5.86 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 912.8 | 10.8 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 912.83 | 11.52 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 913.58 | 5.13 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 913.76 | 11.07 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 913.82 | 11.41 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 914.81 | 11.1 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 914.85 | 11.82 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 915.69 | 10.06 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 915.81 | 10.85 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 916.53 | 5.34 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 916.83 | 11.37 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 917.61 | 6.01 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 917.7 | 10.28 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 917.7 | 10.5 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 917.83 | 11.17 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 918.54 | 5.87 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 918.85 | 11.73 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 919.72 | 10.66 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 919.82 | 11.81 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 920.72 | 10.67 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 920.87 | 11.95 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 921.73 | 10.6 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 921.73 | 10.9 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 921.79 | 11.39 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 921.85 | 11.95 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 922.78 | 10.32 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 922.78 | 10.51 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 923.75 | 11.22 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 923.79 | 10.51 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 923.85 | 12.07 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 924.75 | 11.22 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 924.8 | 10.69 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 925.51 | 5.1 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 925.73 | 10.12 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 925.76 | 11.54 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 925.83 | 11.96 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 926.82 | 11 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 927.78 | 11.86 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 928.75 | 10.51 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 928.82 | 11.56 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 928.85 | 11.93 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 929.82 | 11.04 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 929.83 | 11.24 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 929.84 | 11.91 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 930.76 | 10.67 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 930.85 | 11.57 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 931.54 | 5.1 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 931.85 | 11.57 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 932.78 | 11 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 932.86 | 11.86 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 933.11 | 11.56 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 933.79 | 11.3 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 934.87 | 10.74 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 934.88 | 12.02 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 935.13 | 11.85 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 936.82 | 11.31 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 936.83 | 11.42 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 936.89 | 12.12 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 938.82 | 10.86 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 938.83 | 11.84 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 938.84 | 11.63 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 940.83 | 11.14 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 940.86 | 11.84 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 941.7 | 10.12 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 941.73 | 10.18 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 941.79 | 11.45 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 941.83 | 11.12 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 942.71 | 10.11 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 942.85 | 11.46 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 942.88 | 11.99 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 943.72 | 10.31 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 943.72 | 10.55 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 943.84 | 11.24 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 944.56 | 5.95 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 944.72 | 10.55 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 944.85 | 11.23 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 944.86 | 11.73 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 944.9 | 12.07 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 945.72 | 10.48 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 945.73 | 10.67 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 946.57 | 6.56 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 946.72 | 7.08 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 946.88 | 11.94 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 946.92 | 12.17 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 947.75 | 11.01 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 947.81 | 11.44 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 948.8 | 10.54 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 948.89 | 12.07 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 948.93 | 12.23 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 949.76 | 11.33 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 949.8 | 10.53 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 949.88 | 12.07 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 950.82 | 10.73 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 951.74 | 10.16 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 951.78 | 11.59 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 951.82 | 10.87 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 951.82 | 10.96 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 951.89 | 12.15 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 952.82 | 10.69 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 952.83 | 11.07 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 953.79 | 11.85 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 954.85 | 11.35 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 954.9 | 12.13 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 955.77 | 10.7 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 955.78 | 10.93 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 955.82 | 12.01 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 956.83 | 12.02 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 956.87 | 11.63 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 957.87 | 11.63 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 958.88 | 11.87 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 960.81 | 11.37 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 960.82 | 11.21 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 960.89 | 10.79 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 960.89 | 12.01 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 962.91 | 12.12 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 962.92 | 12.24 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 964.84 | 11.86 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 964.93 | 12.19 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 967.71 | 10.16 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 968.86 | 11.5 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 968.89 | 12.01 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 969.73 | 10.53 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 970.88 | 11.77 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 970.91 | 12.09 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 971.74 | 10.68 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 971.75 | 10.93 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 972.9 | 11.95 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 973.76 | 11.05 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 973.94 | 12.16 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 974.75 | 7.74 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 974.77 | 11.05 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 974.82 | 10.61 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 974.91 | 12.07 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 974.95 | 12.22 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 975.78 | 11.37 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 976.78 | 11.37 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 976.83 | 10.92 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 976.91 | 12.06 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 976.95 | 12.15 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 977.79 | 11.63 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 978.85 | 11.11 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 979.79 | 10.57 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 979.81 | 11.89 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 979.85 | 11.11 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 980.28 | 8.78 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 980.86 | 11.39 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 980.92 | 12.12 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 981.28 | 8.78 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 981.83 | 12.02 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 982.88 | 11.69 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 983.8 | 11.07 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 983.85 | 12.11 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 984.9 | 11.89 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 986.91 | 10.84 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 986.91 | 12.01 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 988.93 | 11.16 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 988.93 | 12.11 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 990.94 | 12.19 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 994.9 | 12.01 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 995.75 | 10.56 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 996.89 | 11.82 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 996.92 | 12.12 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 997.77 | 10.93 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 998.91 | 11.96 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 998.96 | 12.17 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 999.78 | 11.06 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 999.9 | 11.86 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1000.92 | 11.86 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1000.92 | 12.06 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1001.79 | 11.41 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1002.93 | 12.03 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1003.81 | 11.66 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1005.82 | 11.89 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1005.9 | 12.05 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1006.88 | 11.47 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1006.94 | 12.12 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1007.84 | 12.02 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1008.9 | 11.74 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1009.86 | 12.11 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1009.95 | 12.19 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1010.91 | 11.94 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1011.84 | 11.45 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1012.93 | 12.02 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1016.96 | 12.19 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1018.97 | 12.24 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1019.91 | 12.12 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1022.91 | 11.85 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1024.68 | 4.87 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1024.92 | 11.99 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1026.94 | 12.07 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1027.81 | 11.45 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1027.94 | 12.04 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1028.95 | 12.01 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1029.97 | 12.13 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1030.96 | 12.12 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1031.84 | 11.9 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1031.97 | 12.19 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1032.9 | 11.5 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1033.86 | 12.02 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1033.89 | 11.5 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1034.91 | 11.78 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1035.87 | 12.1 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1036.93 | 11.95 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1038.94 | 12.06 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1040.96 | 12.12 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1042.98 | 12.18 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1043.9 | 12.04 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1044.99 | 11.85 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1044.99 | 12.23 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1047 | 12.29 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1049.96 | 12.43 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1054.3 | 9.22 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1056.3 | 9.22 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1057.99 | 12.19 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1060.93 | 11.81 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1061.92 | 11.83 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1062.94 | 11.96 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1064.96 | 12.05 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1066.98 | 12.14 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1069 | 12.17 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1071 | 12.23 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1071.94 | 12.12 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1072.01 | 12.43 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1073.02 | 12.29 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1092.98 | 12.11 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1093 | 12.13 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1095 | 12.19 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1097.02 | 12.23 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1099.03 | 12.28 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1128.32 | 9.62 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1136.8 | 7.56 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1149.84 | 5.85 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1159.85 | 5.86 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1162.35 | 5.86 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1162.85 | 5.86 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1175.36 | 5.9 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1175.86 | 5.89 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1176.36 | 5.89 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1185.35 | 5.86 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1185.85 | 5.86 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1186.02 | 7.21 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1188.87 | 5.93 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1191.83 | 5.86 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1192.33 | 5.86 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1193.84 | 5.86 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001832 | 1199.35 | 5.9 | Minutes | ST001120 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |